Catherine Ellis

Catherine Ellis, Katherine Ellis, or variants of the name, may refer to:

*Catherine Ellis (ethnomusicologist) (1935–1996), Australian academic * Catherine Ellis, presenter of ''The Bounce ''(TV series), a 2010 Australian TV sports program *Kate Ellis (author) (fl. from 1998), British author of crime fiction *Kate Ellis (politician) (born 1977), Australian politician *Katherine Ellis (born 1965), English dance music vocalist and songwriter * Katherine Ellis, American actress in 2001 telemovie ''Motocrossed'' *Kathy Ellis (born 1946), American former swimmer Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'Catherine Ellis', query time: 0.02s Refine Results
  1. 1
    Time Without Transfusion Reliance (TWiTR): Integrating Survival Quality Into Myelofibrosis Treatment Strategies Based on the Phase 3 SIMPLIFY‐1, SIMPLIFY‐2, and MOMENTUM Trials

    Time Without Transfusion Reliance (TWiTR): Integrating Survival Quality Into Myelofibrosis Treatment Strategies Based on the Phase 3 SIMPLIFY‐1, SIMPLIFY‐2, and MOMENTUM Trials by Ruben A. Mesa, Moshe Talpaz, Flora Mazerolle, Boris Gorsh, Manal M'Hari, Antoine Regnault, Catherine Ellis, Zhaohui Wang, Molly Purser, Tom Liu, Bryan Strouse, Dwaipayan Patnaik

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors

    First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors by David Turner, Antoine Italiano, Victor Moreno, Steven Hirschfeld, Juan Martin-Liberal, Michele Maio, Todd M Bauer, Christophe Le Tourneau, Danny Rischin, Catherine Ellis, Eric Angevin, Aaron Hansen, Helen Zhou, Ivan Diaz-Padilla, Frans Opdam, Sapna Yadavilli, Marc Ballas

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours

    CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours by J. Randolph Hecht, Jean-Marie Michot, David Bajor, Amita Patnaik, Ki Y. Chung, Judy Wang, Gerald Falchook, James M. Cleary, Richard Kim, Anuradha Krishnamurthy, Omkar Marathe, Hagop Youssoufian, Catherine Ellis, Angela Waszak, Srimoyee Ghosh, Hailei Zhang, Kaitlin Yablonski, Shruti D. Shah, Ivan Diaz-Padilla, Susanna Ulahannan

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: